Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €1 | €1 | €1 | €1 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €1 | €1 | €1 | €1 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 16.9% | 19.3% | 8.3% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 80.8% | 89.7% | 91.5% | 89.4% |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |
| Net Income | -€0 | -€0 | €0 | €0 |
| % Margin | -3.7% | -4.3% | 6.7% | 8.4% |
| EPS Diluted | -0.015 | -0.013 | 0.015 | 0.018 |
| % Growth | -20.3% | -184.2% | -17.4% | – |
| Operating Cash Flow | -€0 | -€0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | €0 | €0 |